Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gomez

Showing results (111-120 of 479) with videos related to

Pageof 48
Sort By:
AJNR. American Journal of Neuroradiology|September 26, 2000
Radiolabeled leucocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies)J M Murphy, K K Balan, A Toms, et al.
Parasite (Paris, France)|January 8, 1999
The re-emergence of American visceral leishmaniasis in an old focus in Venezuela: present situation of human and canine infectionsO Delgado, M D Feliciangeli, B Gomez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1995
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptorsC Gagnon, B Gomez-Mancilla, R Markstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasisThiruvengadam Arumugam, Vijaya Ramachandran, Sobeyda B Gomez, et al.
American Journal of Preventive Medicine|November 1, 1989
Improving preventive care at a medical clinic: how can the patient help?D M Becker, E B Gomez, D L Kaiser, et al.
Advances in Neurology|January 1, 1993
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeysP J Bédard, B Gomez-Mancilla, P Blanchette, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2020
Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South AfricaFiammetta M Bozzani, Tom Sumner, Don Mudzengi, et al.
The Journal of Infectious Diseases|August 15, 2022
Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United StatesGabriela B Gomez, Christopher B Nelson, Christopher Rizzo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimensA Zwerling, G B Gomez, J Pennington, et al.
Journal of Microbiological Methods|October 29, 2002
Assessment of fluorescent-labeled bacteria for evaluation of in vivo uptake of bacteria (Vibrio spp.) by crustacean larvaeS A Soto-Rodriguez, N Simões, D A Jones, et al.
Pageof 48

Showing results (111-120 of 479) with videos related to

Sort By:
Pageof 48
AJNR. American Journal of Neuroradiology|September 26, 2000
Radiolabeled leucocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies)J M Murphy, K K Balan, A Toms, et al.
Parasite (Paris, France)|January 8, 1999
The re-emergence of American visceral leishmaniasis in an old focus in Venezuela: present situation of human and canine infectionsO Delgado, M D Feliciangeli, B Gomez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1995
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptorsC Gagnon, B Gomez-Mancilla, R Markstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasisThiruvengadam Arumugam, Vijaya Ramachandran, Sobeyda B Gomez, et al.
American Journal of Preventive Medicine|November 1, 1989
Improving preventive care at a medical clinic: how can the patient help?D M Becker, E B Gomez, D L Kaiser, et al.
Advances in Neurology|January 1, 1993
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeysP J Bédard, B Gomez-Mancilla, P Blanchette, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2020
Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South AfricaFiammetta M Bozzani, Tom Sumner, Don Mudzengi, et al.
The Journal of Infectious Diseases|August 15, 2022
Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United StatesGabriela B Gomez, Christopher B Nelson, Christopher Rizzo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimensA Zwerling, G B Gomez, J Pennington, et al.
Journal of Microbiological Methods|October 29, 2002
Assessment of fluorescent-labeled bacteria for evaluation of in vivo uptake of bacteria (Vibrio spp.) by crustacean larvaeS A Soto-Rodriguez, N Simões, D A Jones, et al.
Pageof 48